Thu.Mar 07, 2024

article thumbnail

Boehringer Ingelheim Announces $35 Monthly Price Cap on Inhalers for Asthma, COPD Patients

HCPLive

On March 07, 2024, Boehringer Ingelheim announced it would be instituting a $35 per month out-of-pocket cost cap for its portfolio of inhaler products, with this cap going into effect on June 01, 2024.

140
140
article thumbnail

Case report of belt electrode-skeletal muscle electrical stimulation for acute heart failure with severe obesity: a novel therapeutic option for acute phase rehabilitation

Frontiers in Cardiovascular Medicine

Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy.

article thumbnail

Microplastics linked to heart attack, stroke: Study

Becker's Hospital Review - Cardiology

We all have microplastics in our bodies , but if they show up in carotid artery tissues, patients are nearly two times as likely to experience a stroke, heart attack or related death, according to a study published March 7 in The New England Journal of Medicine.

article thumbnail

Young man with Gunshot wound to right chest with hemorrhagic shock, but bullet path not near heart

Dr. Smith's ECG Blog

A young man presented with a gunshot wound to the right chest, with hemo-pneumothorax and hemorrhagic shock. He got a chest tube and intubation and massive transfusion and stabilized. CT of chest showed the bullet path through his right lung but nowhere near his heart. But he did get an EKG: What is this? There were times when it would be usurped by sinus tachycardia, then return to this rhythm.

article thumbnail

Advanced detection of coronary artery disease via deep learning analysis of plasma cytokine data

Frontiers in Cardiovascular Medicine

The 2017 World Health Organization Fact Sheet highlights that coronary artery disease is the leading cause of death globally, responsible for approximately 30% of all deaths. In this context, machine learning (ML) technology is crucial in identifying coronary artery disease, thereby saving lives. ML algorithms can potentially analyze complex patterns and correlations within medical data, enabling early detection and accurate diagnosis of CAD.

article thumbnail

The Evolving Computed Tomography Market

DAIC

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 billion, and expected to reach $3.18 billion by 2029, growing at a CAGR of 5.86% in the forecast period (2024-2029), according to a new report released by Mordor Intelligence.

article thumbnail

10,000 Steps Lowers Death Risk; Obesity Drug Beats Wegovy; Lead in Cinnamon Warning

Med Page Today

(MedPage Today) -- Note that some links may require registration or subscription. Accruing about 10,000 steps per day was associated with the lowest mortality risk independent of sedentary time, but any amount above 2,200 steps a day showed mortality.

Obesity 110

More Trending

article thumbnail

One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia?

Med Page Today

(MedPage Today) -- Use of GLP-1 receptor agonists was linked with increased residual gastric content on preprocedural gastric ultrasonography, even after fasting for the guideline-recommended duration, a cross-sectional study showed. In 124 patients.

107
107
article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

milla1cf Thu, 03/07/2024 - 20:01 March 7, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions for cardiovascular disorders, today announced positive interim results from the Phase III randomized controlled trial of its CardiAMP autologous cell therapy in 110 randomized patients with advanced chronic heart failure at a mean 20-month follow-up, ( CardiAMP HF ).

article thumbnail

How Gene and Cell Therapy Is Developing in Dermatology

HCPLive

Peter Marinkovich, MD, reflects on the significant growth in advanced therapy development, particularly in rare skin diseases.

105
105
article thumbnail

Siemens Healthineers Launches Cinematic Reality App for Apple Vision Pro

DAIC

milla1cf Thu, 03/07/2024 - 20:23 March 7, 2024 — Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as surgeons, medical students, and patients to view immersive, interactive holograms of the human body captured through medical scans in their real-world environment. Visualizing the renderings through the app could assist in surgical planning and medical education, or help patients visualize procedures.

Education 105
article thumbnail

Reviewing New Molluscum Therapies, with Nanette B. Silverberg, MD

HCPLive

The FDA approved the first 2 therapies to treat molluscum contagiosum in the last year. Silver explains how it's provided more than just treatment options.

105
105
article thumbnail

Children with 'lazy eye' are at increased risk of serious disease in adulthood

Science Daily - Heart Disease

Adults who had amblyopia ('lazy eye') in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study.

article thumbnail

GE HealthCare to Spotlight Industry-Leading AI-Enabled Portfolio and Digital Solutions at HIMSS 2024

DAIC

milla1cf Thu, 03/07/2024 - 20:10 March 7, 2024 — GE HealthCare will showcase its industry-leading portfolio of artificial intelligence ( AI )-enabled medical devices and digital solutions in Booth 2500 at the Health Information and Management Systems Society ( HIMSS ) Global Health Conference and Exhibition in Orlando, FL from March 11-15, 2024. In the U.S., clinicians spend nearly twice as much time working with electronic health records as working with patients.i This challenge is only incre

article thumbnail

Teen Topics – The Top 10 Things to Remember About CHD as an Adult

Conquering CHD

It often seems that the “taboo topics” in life aren’t really all that relevant until your teen years. As the seasons change, new milestones come and go. This can be an especially trying time in the life of an adolescent with congenital heart disease, especially as they are undergoing the major transition of leaving the nest and going off to college, joining the workforce, or just moving far from home.

article thumbnail

FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24

DAIC

The American College of Cardiology (ACC) has announced its stellar line-up of keynote speakers for the 73rd Annual Scientific Session & Expo, ACC.24, including U.S. Food and Drug Administration Commissioner Robert M. Califf, MD, MACC, among a host of highly-regarded cardiovascular thought leaders and practitioners. The 3-day conference will be held April 6 - 8, at the Georgia World Congress Center in Atlanta, GA.

article thumbnail

The US Department of Veterans Affairs Announces Adoption of Adalimumab-bwwd, with Jon Martin

HCPLive

Jon Martin, US Commercial Lead of Biosimilars at Organon, discusses the decision to select biosimilar adalimumab-bwwd and its potential implications on the pharmaceutical market.

95
article thumbnail

Changes in right ventricular function and clinical outcomes following tricuspid transcatheter edge?to?edge repair

European Journal of Heart Failure

Changes in right ventricular (RV) function and clinical outcomes after tricuspid transcatheter edge-to-edge repair (T-TEER). RVFAC, right ventricular fractional area change; TR, tricuspid regurgitation Abstract Aims Prognostic impact of post-procedural changes in right ventricular (RV) function after tricuspid transcatheter edge-to-edge repair (T-TEER) is still unclear.

article thumbnail

Palliative Care Across the HF Spectrum: Key Points

American College of Cardiology

The following are key points to remember from a state-of-the-art review on palliative care across the spectrum of heart failure (HF).

article thumbnail

Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial

European Journal of Heart Failure

Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial. CV, cardiovascular; HF, heart failure. Aims In VICTORIA, vericiguat compared with placebo reduced the risk of cardiovascular death (CVD) and heart failure hospitalization (HFH) in patients enrolled after a worsening heart failure (WHF) event.

article thumbnail

3 Tried and True Methods of Pediatric Eczema Management

HCPLive

Lawrence Eichenfield, MD, reviews prescription and at-home care strategies for pediatric atopic dermatitis, as well as the best measures of disease monitoring.

article thumbnail

Mendelian randomization supports genetic liability to hospitalization for COVID-19 as a risk factor of pre-eclampsia

Frontiers in Cardiovascular Medicine

Background Pre-eclampsia and eclampsia are among the major threats to pregnant women and fetuses, but they can be mitigated by prevention and early screening. Existing observational research presents conflicting evidence regarding the causal effects of coronavirus disease 2019 (COVID-19) on pre-eclampsia risk. Through Mendelian randomization (MR), this study aims to investigate the causal effect of three COVID-19 severity phenotypes on the risk of pre-eclampsia and eclampsia to provide more rigo

article thumbnail

Novo Nordisk Delivers Updates on Development of Semaglutide, CagriSema, Amycretin, and More

HCPLive

On March 07, 2024, Novo Nordisk provided updates on semaglutide 2.4 mg as well as the development programs cagrisema, monlunabant, and amycretin.

64
article thumbnail

5 cardiologist employment stats to know

Becker's Hospital Review - Cardiology

Discover the latest employment data for cardiologists in the US, including mean annual wage, top paying states and metropolitan areas, and employment locations

64
article thumbnail

FDA Approves Biosimilar Tocilizumab-aazg for the Treatment of Autoimmune Diseases

HCPLive

The drug is the first tocilizumab biosimilar with an FDA-approved intravenous and subcutaneous formulation.

59
article thumbnail

Micro and Nanoplastics and Cardiovascular Events – Recent Study

All About Cardiovascular System and Disorders

Use of plastics in daily life is currently on the increase and it is a well known pollutant in our water bodies like rivers, ponds, lakes and ocean. Plastics can be degraded into microplastics which are smaller than 5 mm and nanoplastics which are smaller than 1000 nanometer [1]. Microplastics and nanoparticles can trigger toxicologic effects in the body [2].

Plaque 52
article thumbnail

Celebrating 30 Years of Camp Discovery, with Susan Boiko, MD

HCPLive

Boiko discusses the annual weeklong summer camp for children and adolescents with skin diseases to make connections, experience camp with the support of volunteer specialists, and find comfort with their condition.

59
article thumbnail

Interventions Can Reduce CVD Risk Factors in HIV Patients, Studies Show

Med Page Today

(MedPage Today) -- DENVER -- Efforts aimed at lowering blood pressure (BP) and cholesterol in people with HIV can succeed, two randomized trials presented here demonstrated. In the first, prehypertensive Haitians on stable antiretroviral therapy.

article thumbnail

Clinical Quiz: Methotrexate for Pediatric Dermatoses

HCPLive

In recognition of the Pre-AAD 2024 meeting, take our quiz based on Society for Pediatric Dermatology resources.

article thumbnail

Google Cloud Leader and High-Profile Keynote Speakers to be Featured at HIMSS24

DAIC

With just days to go before HIMSS 2024, the Global Conference and Exhibition of the Healthcare Information and Management Systems Society (HIMSS), program planners are highlighting keynote speakers to be presented during the March 11-15 event to be held in Orlando, FL, including Matt Renner, President of North America and Global Startups at Google Cloud, among others noted in this program update.

article thumbnail

CGM Use in Type 1 Diabetes Management May Mitigate Risk of Retinopathy

HCPLive

Continuous glucose monitoring was associated with lower odds of diabetic retinopathy development, even after adjusting for hemoglobin A1c levels.

article thumbnail

Changes to MIPS 2024: What Cardiology Clinics Need to Know, Including Quality Payment Program

GEMMS

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). The changes have an impact on the traditional Merit-Based Incentive Payment System (MIPS), adjustments in reporting for Alternative Payment Models (APMs) and Accountable Care Organizations (ACOs), and the expansion of MIPS Value Pathways (MVPs).

article thumbnail

Clinical Quiz: AAD Guideline Updates for the Management of Acne

HCPLive

The AAD's Acne Management Guidelines include updates to the recommendations for treating acne and aims to assist clinicians and patients in making informed decisions on acne management. Test your knowledge with this quiz.

52
article thumbnail

Mitral valvular surgery outcomes in a centre with a dedicated mitral multi-disciplinary team

The British Journal of Cardiology

International guidelines recommend ‘heart teams’ as the preferred method for decision-making. Heart team processes, mandatory attendees and investigations vary significantly between hospitals. We assessed outcomes following mitral valvular surgery in a tertiary referral centre with a dedicated mitral multi-disciplinary team (MDT). This was a single-centre retrospective review of prospectively collected data within the ‘mitral database’ of mitral valvular disease patients.

article thumbnail

Presentation of and Challenges in Treatment of Psoriasis in Patients With Skin of Color

HCPLive

Expert dermatologists review the presentation of psoriasis in patients with skin of color and the challenges physicians face in diagnosing psoriasis in this patient population.

52
article thumbnail

Navigating the research landscape in cardiology. Part 2: finding the right research

The British Journal of Cardiology

This editorial series provides an in-depth exploration of research avenues in UK cardiology. It underscores the pivotal role of research in cardiology training and addresses the challenges faced by trainees in identifying apt research opportunities. This second article categorises available research roles, weighing their pros and cons, and outlines various supervisory styles to guide trainees in finding the optimal fit.

article thumbnail

Social and Cultural Stigma of Psoriasis in Patients With Skin of Color

HCPLive

Drs Stein Gold, Shahriari and Desai highlight social and cultural stigma of psoriasis in patients with skin of color and its impact on patient’s quality of life.